Ran BP-10 inhibitors are a class of chemical compounds that specifically target and inhibit the function of Ran BP-10, a member of the Ran-binding protein family involved in regulating nucleocytoplasmic transport. Ran BP-10 plays a critical role in facilitating the transport of proteins and RNA molecules between the nucleus and cytoplasm, a process crucial for maintaining cellular function and gene expression. Like other Ran-binding proteins, Ran BP-10 interacts with Ran GTPase, a molecular switch that alternates between its GTP-bound active state and GDP-bound inactive state. This cycling process governs the directional movement of cargo proteins across the nuclear envelope. Ran BP-10 likely assists in modulating the interactions between Ran GTPase and its cargo, helping ensure the proper trafficking of molecules necessary for cellular metabolism, signal transduction, and the maintenance of nuclear integrity. Inhibitors of Ran BP-10 act by disrupting its ability to bind to Ran GTPase or by interfering with its role in the nucleocytoplasmic transport machinery.
The inhibition of Ran BP-10 can lead to significant disruptions in processes dependent on effective nuclear-cytoplasmic transport, such as gene expression, protein localization, and cell cycle progression. By blocking Ran BP-10's activity, these inhibitors impair the trafficking of essential macromolecules, which can affect protein synthesis and the overall coordination of cellular responses to environmental signals. Researchers use Ran BP-10 inhibitors to study the specific contributions of this protein to nuclear transport mechanisms and to investigate its involvement in broader cellular processes, such as mitosis and DNA replication. These inhibitors also provide valuable insights into how the Ran GTPase cycle is fine-tuned by various Ran-binding proteins to ensure efficient intracellular communication and the exchange of molecular signals. By studying Ran BP-10 inhibitors, scientists gain a deeper understanding of the dynamic processes that govern nuclear transport and how disruptions in these processes can affect cellular organization and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, blocks the activation of MAPK/ERK pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Specific inhibitor of phosphoinositide 3-kinases (PI3Ks). | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, halts the p38 MAPK signaling pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho-associated protein kinase (ROCK) inhibitor. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK signaling pathway by targeting JNK1/2/3. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibits Wnt processing, blocking the Wnt signaling pathway. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Aurora kinase inhibitor, influencing mitotic processes. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
Cysteine protease inhibitor. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII). | ||||||